National Institute on Drug Abuse; Notice of Closed Meetings, 36873 [2020-13096]

Download as PDF Federal Register / Vol. 85, No. 118 / Thursday, June 18, 2020 / Notices Development Award for Clinicians, Scientist Development Awards, and Research Scientist Awards; 93.278, Drug Abuse National Research Service Awards for Research Training; 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications/ contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications/ contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; SEP II: Step Up for Substance Use Disorders (SUD): A Drug Target Initiative for Scientists Engaged in Fundamental Research (U18— Clinical Trial Not Allowed). Date: June 23, 2020. Time: 9:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neurosciences Center Building, 6001 Executive Boulevard, Rockville, MD 20852 (Virtual Meeting). Contact Person: Trinh T. Tran, Ph.D., Scientific Review Officer, Office of Extramural Policy and Review, Division of Extramural Research, National Institute on Drug Abuse, NIH, 6001 Executive Boulevard, Room 4238, MSC 9550, Bethesda, MD 20892, (301) 827–5843, trinh.tran@nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; NIDA Developmental Studies Biorepository and Analysis Center. Date: July 14, 2020. Time: 12:00 p.m. to 5:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, Neurosciences Center Building, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Yvonne Owens Ferguson, Ph.D., Scientific Review Officer, Office of Extramural Policy and Review, Division of Extramural Research, National Institute on Drug Abuse, NIH, 6001 Executive Boulevard, Room 4234, Bethesda, MD 20892, (301) 402– 7371, yvonne.ferguson@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist VerDate Sep<11>2014 18:29 Jun 17, 2020 Jkt 250001 Dated: June 12, 2020. Tyeshia M. Roberson, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–13096 Filed 6–17–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY Office of the Secretary [Docket No. DHS–2020–0024] DHS Data Privacy and Integrity Advisory Committee Privacy Office, DHS. Committee Management; notice of committee charter renewal. AGENCY: ACTION: The Secretary of Homeland Security has determined that the renewal of the Data Privacy and Integrity Advisory Committee is necessary and in the public interest in connection with the Department of Homeland Security’s performance of its duties. This determination follows consultation with the Committee Management Secretariat, General Services Administration. DATES: The committee’s charter is effective June 10, 2020 and expires June 10, 2022. ADDRESSES: If you desire to submit comments on this action, they must be submitted by August 9, 2020. Comments must be identified by DHS Docket Number (DHS–2020–0024) and may be submitted by one of the following methods: • Federal eRulemaking Portal: https:// www.regulations.gov. Follow the instructions for submitting comments. • Email: PrivacyCommittee@dhs.gov. Include the Docket Number (DHS– 2020–0024) in the subject line of the message. • Fax: (202) 343–4010. • Mail: Nicole Sanchez, Designated Federal Officer, Data Privacy and Integrity Advisory Committee, Department of Homeland Security, Privacy Office, Mail Stop 0655, 2707 Martin Luther King Jr. Ave. SE, Washington, DC 20528–0655. Instructions: All submissions must include the words ‘‘Department of Homeland Security’’ and DHS–2020– 0024, the docket number for this action. SUMMARY: PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 36873 Comments received will be posted without alteration at https:// www.regulations.gov, including any personal information provided. Docket: For access to the docket to read background documents or comments received, go to https:// www.regulations.gov. FOR FURTHER INFORMATION CONTACT: Nicole Sanchez, Designated Federal Officer, DHS Data Privacy and Integrity Advisory Committee, Department of Homeland Security, Privacy Office, Mail Stop 0655, 2707 Martin Luther King Jr. Ave. SE, Washington, DC 20528–0655, by telephone (202) 343–1717, by fax (202) 343–4010, or by email to privacycommittee@hq.dhs.gov. Responsible DHS Officials: Constantina Kozanas, Chief Privacy Officer, and Nicole Sanchez, Designated Federal Officer, 245 Murray Lane SW, Mail Stop 0655, Washington, DC 20528, PrivacyCommittee@dhs.gov, (202) 343– 1717. Purpose and Objective: Under the authority of 6 U.S.C. 451, this charter renewed the Data Privacy and Integrity Advisory Committee as a discretionary committee, which shall operate in accordance with the provisions of the Federal Advisory Committee Act (FACA), 5 U.S.C. Appendix. The Committee provides advice at the request of the Secretary and the Chief Privacy Officer of the Department of Homeland Security (DHS) (hereinafter ‘‘the Chief Privacy Officer’’) on programmatic, policy, operational, security, administrative, and technological issues within DHS that relate to personally identifiable information (PII), as well as data integrity, transparency, and other privacy-related matters. SUPPLEMENTARY INFORMATION: Dated: June 15, 2020. Constantina Kozanas, Chief Privacy Officer, Department of Homeland Security. [FR Doc. 2020–13143 Filed 6–17–20; 8:45 am] BILLING CODE 9110–9L–P DEPARTMENT OF HOMELAND SECURITY Office of the Secretary [Docket No. DHS–2020–0025] DHS Data Privacy and Integrity Advisory Committee; Appointments Department of Homeland Security Privacy Office. AGENCY: E:\FR\FM\18JNN1.SGM 18JNN1

Agencies

[Federal Register Volume 85, Number 118 (Thursday, June 18, 2020)]
[Notices]
[Page 36873]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-13096]



[[Page 36873]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications/contract proposals and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications/contract 
proposals, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; SEP II: Step Up for Substance Use Disorders (SUD): A 
Drug Target Initiative for Scientists Engaged in Fundamental 
Research (U18--Clinical Trial Not Allowed).
    Date: June 23, 2020.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neurosciences Center 
Building, 6001 Executive Boulevard, Rockville, MD 20852 (Virtual 
Meeting).
    Contact Person: Trinh T. Tran, Ph.D., Scientific Review Officer, 
Office of Extramural Policy and Review, Division of Extramural 
Research, National Institute on Drug Abuse, NIH, 6001 Executive 
Boulevard, Room 4238, MSC 9550, Bethesda, MD 20892, (301) 827-5843, 
[email protected].

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; NIDA Developmental Studies Biorepository and 
Analysis Center.
    Date: July 14, 2020.
    Time: 12:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, Neurosciences Center 
Building, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone 
Conference Call).
    Contact Person: Yvonne Owens Ferguson, Ph.D., Scientific Review 
Officer, Office of Extramural Policy and Review, Division of 
Extramural Research, National Institute on Drug Abuse, NIH, 6001 
Executive Boulevard, Room 4234, Bethesda, MD 20892, (301) 402-7371, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse and Addiction Research Programs, National 
Institutes of Health, HHS)

    Dated: June 12, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-13096 Filed 6-17-20; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.